Rafferty Asset Management, LLC Agios Pharmaceuticals, Inc. Transaction History
Rafferty Asset Management, LLC
- $22.9 Billion
- Q1 2025
A detailed history of Rafferty Asset Management, LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 93,627 shares of AGIO stock, worth $3.35 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
93,627
Previous 70,313
33.16%
Holding current value
$3.35 Million
Previous $2.31 Million
18.74%
% of portfolio
0.01%
Previous 0.01%
Shares
25 transactions
Others Institutions Holding AGIO
# of Institutions
237Shares Held
60.1MCall Options Held
323KPut Options Held
367K-
Farallon Capital Management LLC San Francisco, CA5.7MShares$204 Million0.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$200 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$174 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$126 Million2.39% of portfolio
-
State Street Corp Boston, MA2.45MShares$87.6 Million0.0% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.96B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...